BMPS:MILBanca Monte dei Paschi di Siena S.p.A. Analysis
Data as of 2026-03-10 - not real-time
€7.39
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Valuation appears compelling: the price‑to‑earnings multiple is well below the sector average and the price‑to‑book ratio is under one, suggesting a significant discount. Dividend yield is in the double‑digit range and the payout ratio is moderate, making the stock attractive for income‑focused investors. Technical indicators show the stock is trading below its short‑term moving averages with a bearish MACD, yet the relative strength index sits near the oversold zone and volume is on the rise, hinting at potential short‑term upside. The current price is comfortably above the identified support level and well below the nearby resistance, offering a clear risk‑reward profile.
Recent corporate actions have bolstered the outlook: the acquisition of a controlling stake in Mediobanca and a net‑profit surprise have reinforced earnings momentum and positioned the bank for synergies. However, an insider‑trading probe involving a board member adds a layer of regulatory uncertainty, and the high 30‑day volatility underscores price swings. Overall, the blend of deep valuation discounts, strong dividend appeal, and improving earnings suggests a buy stance, tempered by medium‑term regulatory and market risks.
Recent corporate actions have bolstered the outlook: the acquisition of a controlling stake in Mediobanca and a net‑profit surprise have reinforced earnings momentum and positioned the bank for synergies. However, an insider‑trading probe involving a board member adds a layer of regulatory uncertainty, and the high 30‑day volatility underscores price swings. Overall, the blend of deep valuation discounts, strong dividend appeal, and improving earnings suggests a buy stance, tempered by medium‑term regulatory and market risks.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- oversold RSI indicating near‑term rebound potential
- high dividend yield offering immediate income
- price positioned above strong support with increasing volume
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- integration of Mediobanca stake could drive earnings
- regulatory investigation may create uncertainty
- moderate volatility may cause price fluctuations
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- deep valuation discount relative to peers
- sustainable value proposition from low P/E and P/B
- consistent high dividend yield supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth94.70%
Profit Margin59.54%
P/E Ratio4.8
ROE12.98%
ROA1.49%
P/B Ratio0.8
Industry P/E17.3
Technical Analysis
TrendNeutral
RSI35.2
Support€6.85
Resistance€9.03
MA 20€8.17
MA 50€8.64
MA 200€7.90
MACDBearish
VolumeIncreasing
Fear & Greed Index76.91
Valuation
Target Price€10.28
Upside/Downside39.03%
GradeUndervalued
TypeBlend
Dividend Yield12.21%
Risk Assessment
Beta0.66
Volatility42.29%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.